Neither misoprostol nor D&C is categorically safer than the other. Both are well-established options for managing early pregnancy loss, and major medical guidelines consider them equally acceptable when there are no complicating factors like active infection or heavy bleeding. The right choice depends on your specific medical situation, your preferences, and what risks matter most to you.
Each method carries a different set of tradeoffs. Misoprostol avoids surgery and anesthesia but takes longer and sometimes doesn’t fully work. A D&C resolves things quickly but introduces surgical risks, however small. Here’s what the evidence says about each.
How Each Method Works
Misoprostol is a medication that causes the uterus to contract and expel pregnancy tissue. You take it at home (usually vaginally or dissolved between your cheek and gum), and the process unfolds over hours to days. It essentially accelerates what would happen naturally during a miscarriage, with heavier cramping and bleeding than a normal period.
A D&C (dilation and curettage) is a short outpatient procedure. Your cervix is gently opened, and the pregnancy tissue is removed with suction or a thin instrument. It typically takes 10 to 15 minutes and is done under sedation or local anesthesia in a clinic or hospital.
Risks of Misoprostol
The main risk of misoprostol is that it doesn’t completely clear the uterine tissue. When this happens, you may need a follow-up D&C anyway, which means going through both experiences. Success rates for misoprostol in early pregnancy loss are generally around 80 to 90 percent, depending on the dose and timing, but that means roughly 1 in 5 to 1 in 10 people will need surgical intervention afterward.
Bleeding with misoprostol is heavier and lasts longer than with a D&C. It’s common to bleed for one to two weeks, and some people experience bleeding that tapers on and off for several weeks. Cramping can be intense, particularly in the first several hours after taking the medication. Nausea, diarrhea, and fever are also common side effects of the drug itself, though these are typically short-lived.
The infection rate with misoprostol is comparable to that of D&C. Studies have not found a meaningful difference in pelvic infection rates between the two approaches.
Risks of D&C
Because D&C is a surgical procedure, it carries risks that misoprostol does not. Uterine perforation, where the instrument passes through the uterine wall, occurs in roughly 0.5% of first-trimester procedures. This is rare, and most perforations heal without further surgery, but it’s a risk that simply doesn’t exist with medication.
There’s also the matter of intrauterine adhesions, sometimes called Asherman syndrome, where scar tissue forms inside the uterus after instrumentation. A study of over 2,500 women who underwent uterine curettage found the incidence was 1.6%. These adhesions can affect future periods and, in some cases, fertility. The risk is small but worth knowing about if you plan future pregnancies.
Any procedure involving sedation or anesthesia adds another layer of risk, including allergic reactions, breathing complications, and nausea. For most healthy people, these risks are very low, but they are essentially zero with misoprostol since no anesthesia is involved.
Recovery and What to Expect
Recovery timelines differ significantly. After a D&C, most people experience mild cramping and light spotting for a few days and can return to normal activities within a day or two. The process is predictable: you go in, the procedure happens, and it’s done.
With misoprostol, the timeline is less predictable. Heavy bleeding and strong cramps typically begin within a few hours of taking the medication and can last for a day or more. Lighter bleeding continues for one to two weeks afterward. Some people pass the tissue quickly, while others need a second dose or wait several days. That unpredictability is, for many people, the hardest part.
When One Option Is Clearly Safer
There are specific situations where one method is medically preferred over the other. Misoprostol should not be used if you have an active pelvic infection, signs of sepsis, a confirmed or suspected ectopic pregnancy, a known bleeding disorder, are on blood-thinning medication, or are in hemodynamic shock (meaning dangerously low blood pressure from blood loss). In these cases, a D&C is the safer and often urgent choice.
On the other hand, misoprostol may be the better option if you want to avoid anesthesia, have conditions that make surgery riskier, or simply prefer to manage the process at home. People with serious heart, kidney, or liver disease, or severe anemia, need individual evaluation to determine which approach carries fewer risks for their specific situation.
How to Think About the Choice
If your main concern is avoiding surgical complications and anesthesia, misoprostol is the lower-risk path. If your main concern is making sure the process is complete, predictable, and over quickly, a D&C offers that. The overall complication rates for both methods are low, and neither carries a dramatically higher risk of serious harm than the other.
For many people, the deciding factors aren’t purely medical. Some prefer the privacy and control of managing a miscarriage at home. Others find comfort in the certainty of a procedure with a clear beginning and end. Both responses are completely reasonable, and the American College of Obstetricians and Gynecologists explicitly states that when there are no urgent medical complications, treatment plans can safely accommodate patient preferences.
If you’re leaning toward misoprostol, it helps to have a plan in place for what happens if it doesn’t work completely, since there’s a real chance you’ll still need a D&C. If you’re leaning toward a D&C, know that the surgical risks, while real, are quite small for a first-trimester procedure.